Corbus Pharma (CRBP) Reports Q4 Loss of $0.28/Share

Corbus Pharma (NASDAQ: CRBP) reported Q4 EPS of ($0.28), versus ($0.13) reported last year. Revenue for the quarter came in at $648.4 thousand, versus $0 reported last year.

For earnings history and earnings-related data on Corbus Pharma (CRBP) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Investcorp Credit Management BDC, Inc. (ICMB) Misses Q2 EPS by 12c
• Greenlane Holdings Inc. (GNLN) reported Q2 result